VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Canadian Pacific Kansas City Limited vs Gilead Sciences, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Canadian Pacific Kansas City Limited
CP · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Canadian Pacific Kansas City Limited's moat claims, evidence, and risks.
View CP analysisGilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 70 / 100 for Canadian Pacific Kansas City Limited).
- Segment focus: Canadian Pacific Kansas City Limited has 4 segments (46% in Merchandise Freight); Gilead Sciences, Inc. has 5 segments (68.5% in HIV).
- Moat breadth: Canadian Pacific Kansas City Limited has 4 moat types across 2 domains; Gilead Sciences, Inc. has 8 across 3.
Primary market context
Canadian Pacific Kansas City Limited
Merchandise Freight
North American carload rail freight (industrial and consumer commodities)
Canada, United States, Mexico
Industrial shippers and manufacturers across multiple commodity groups
Rail carrier + logistics/transload provider
46%
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Canadian Pacific Kansas City Limited strengths
Gilead Sciences, Inc. strengths
Segment mix
Canadian Pacific Kansas City Limited segments
Full profile >Bulk Freight
Oligopoly
Merchandise Freight
Oligopoly
Intermodal Freight
Competitive
Non-freight and Other
Competitive
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.